Article abstract
Nature Chemical Biology 3, 287 - 296 (2007)
Published online: 15 April 2007 | doi:10.1038/nchembio874
Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants
Qiaojie Xiong1, Haiyan Sun1 & Min Li1
Abstract
KCNQ potassium channels are activated by changes in transmembrane voltage and play an important role in controlling electrical excitability. Human mutations of KCNQ2 and KCNQ3 potassium channel genes result in reduction or loss of channel activity and cause benign familial neonatal convulsions (BFNCs). Thus, small molecules capable of augmenting KCNQ currents are essential both for understanding the mechanism of channel activity and for developing therapeutics. We performed a high-throughput screen in search for agonistic compounds potentiating KCNQ potassium channels. Here we report identification of a new opener, zinc pyrithione (1), which activates both recombinant and native KCNQ M currents. Interactions with the channel protein cause an increase of single-channel open probability that could fully account for the overall conductance increase. Separate point mutations have been identified that either shift the concentration dependence or affect potentiation efficacy, thereby providing evidence for residues influencing ligand binding and downstream events. Furthermore, zinc pyrithione is capable of rescuing the mutant channels causal to BFNCs.
- Department of Neuroscience, High Throughput Biology Center and Department of Physiology, School of Medicine, Johns Hopkins University, 733 North Broadway, Baltimore, Maryland 21205, USA.
Correspondence to: Min Li1 e-mail: minli@jhmi.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
A new wave for heart rhythmsNature News and Views (07 Nov 1996)
Making a submicroscopic hole in oneNature News and Views (21 Feb 1991)
RESEARCH
Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificityCancer Gene Therapy Original Article
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transferNature Immunology Article (01 Oct 2001)
See all 62 matches for Research
